Company: MYGN
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0000899923-25-000112
Chunk: 19

Company: MYRIAD GENETICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 19
---
— — 12.4 Net loss— — — (22.1)(22.1)Other comprehensive income, net of tax— — 3.9 — 3.9 BALANCES AT SEPTEMBER 30, 2024$0.9 $1,445.2 $(0.1)$(714.3)$731.7 BALANCES AT DECEMBER 31, 2024$0.9 $1,457.8 $(0.8)$(756.8)$701.1 Issuance of common stock under stock-based compensation plans, net of shares exchanged for withholding tax— (5.8)— — (5.8)Stock-based compensation expense— 9.5 — — 9.5 Net loss— — — (0.1)(0.1)Other comprehensive income, net of tax— — 0.2 — 0.2 BALANCES AT MARCH 31, 2025$0.9 $1,461.5 $(0.6)$(756.9)$704.9 Issuance of common stock under stock-based compensation plans, net of shares exchanged for withholding tax— 2.5 — — 2.5 Stock-based compensation expense— 10.7 — — 10.7 Net loss— — — (330.5)(330.5)Other comprehensive income, net of tax— — 0.5 — 0.5 BALANCES AT JUNE 30, 2025$0.9 $1,474.7 $(0.1)$(1,087.4)$388.1 Issuance of common stock under stock-based compensation plans, net of shares exchanged for withholding tax— (0.1)— — (0.1)Stock-based compensation expense— 12.2 — — 12.2 Net loss— — — (27.4)(27.4)BALANCES AT SEPTEMBER 30, 2025$0.9 $1,486.8 $(0.1)$(1,114.8)$372.8 

See accompanying notes to Condensed Consolidated Financial Statements.

7

MYRIAD GENETICS, INC.

AND SUBS